Other studies have revealed that genomic alterations (mutations/deletions) or epigenetic changes (hypermethylation) in KEAP1 lead to its loss of function, along with overexpression of NRF2 and its downstream genes in lung cancer [17, 18]. Here, KEAP1 is linked to lung cancer.